Aecom vs Medtronic PLC — how do they compare? Aecom trades at $67.13 (market cap $9.42B), while Medtronic PLC trades at $90.5 (market cap $114.45B). The key difference: Medtronic PLC is far larger — about 12.1× Aecom's market cap, and Medtronic PLC pays the higher dividend (3.22%). Which is the better fit depends on your goals.
| ACM | MDT | |
|---|---|---|
Market Cap | $9.42B | $114.45B |
Sector | Industrials | Health |
52-Week High | $134.35 | $105.35 |
52-Week Low | $66.86 | $73.75 |
Enterprise Value | $11.60B | $133.19B |
Dividend Yield | 1.62% | 3.22% |
Signals from Pluang's Aura AI — not financial advice
ACM trades at $75.84, up 1.21% daily, with a bullish technical signal from moving averages and ADX indicators. Recent Q2 2026 earnings missed expectations with a loss of $0.50 per share, though revenue trends remain stable near $16 billion annually. The company secured new infrastructure projects in Australia and Portugal, supporting a record backlog. Valuation metrics show a P/E of 15.83 and P/S of 0.63, below sector averages, indicating potential undervaluation.
Outlook is mixed: strong analyst consensus (64% buy) and a $99.20 price target suggest 31% upside, but Q2 miss and rising debt-to-asset ratio (22.61% in 2025) pose risks. Investors should weigh robust contract wins against earnings volatility and macroeconomic pressures on infrastructure spending.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Aecom is one of the largest global providers of design, engineering, construction, and management services. The firm serves a broad spectrum of end markets including infrastructure, water, transportation, and energy. Based in Los Angeles, Aecom has a presence in over 150 countries and employs 51,000. The company generated $13.3 billion in sales and $701 million in adjusted operating income in fiscal 2021.
Read more on ACM →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →